Advertisement

Archives of Gynecology and Obstetrics

, Volume 297, Issue 5, pp 1175–1179 | Cite as

Expression of semaphorin class 3 is higher in the proliferative phase on the human endometrium

  • Gustavo Dias Ferreira
  • Edison Capp
  • Julia Jauckus
  • Thomas Strowitzki
  • Ariane Germeyer
General Gynecology
  • 86 Downloads

Abstract

Purpose

The semaphorins are related to angiogenesis and cell proliferation depending on the tissue. The purpose of this study was to assess gene expression of class 3 semaphorin (SEMA3A-F) and protein expression of semaphorin 3A (SEMA3A) within human endometrium throughout the menstrual cycle.

Methods

Gene expression of SEMA3A-F was analyzed by real-time PCR (qRT-PCR) and protein expression of SEMA3A was analyzed by ELISA in endometrial biopsies in the proliferative and secretory phase of the menstrual cycle.

Results

Gene expression of SEMA3A, SEMA3C, SEMA3D, and SEMA3E was statistically significant decreased in secretory compared to proliferative phase endometrium (p < 0.05). Accordingly, SEMA3A protein expression in the secretory phase was lower than protein expression in proliferative phase endometrium (p ≤ 0.05).

Conclusion

SEMA3A, 3C, 3D, and 3E are possibly related to cell proliferation in the endometrium, being more expressed in the proliferative phase of the cycle. This finding may stimulate studies of class 3 semaphorins as a possible target for treatment of endometrial pathologies.

Keywords

Endometrium Semaphorin Menstrual cycle SEMA3 

Notes

Acknowledgements

Gustavo Dias Ferreira was scholarship recipient from CAPES—Process Number 18471-12-9.

Author contributions

GDF project development, data management, data analysis, and manuscript writing. EC and AG project development, data analysis, and manuscript editing. JJ project development and data management. TS project development, data collection, and manuscript editing.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This project was approved by the Ethics Committee of the Medical Faculty of the Heidelberg University (Number 239-05).

References

  1. 1.
    Yazdani U, Terman JR (2006) The semaphorins. Genome Biol 7(3):211CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Movassagh H, Khadem F, Gounni AS (2018) Semaphorins and their roles in airway biology: potential as therapeutic targets. Am J Respir Cell Mol Biol 58(1):21–27CrossRefPubMedGoogle Scholar
  3. 3.
    Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir-Zvi I, Ziv K, Kessler O (2016) The role of the semaphorins in cancer. Cell Adhes Migr 10(6):652–674CrossRefGoogle Scholar
  4. 4.
    Mann F, Chauvet S, Rougon G (2007) Semaphorins in development and adult brain: implication for neurological diseases. Prog Neurobiol 82(2):57–79CrossRefPubMedGoogle Scholar
  5. 5.
    Tamagnone L, Comoglio PM (2004) To move or not to move? Semaphorin signalling in cell migration. EMBO Rep 5(4):356–361CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Chauvet S, Cohen S, Yoshida Y, Fekrane L, Livet J, Gayet O et al (2007) Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development. Neuron 56(5):807–822CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Falk J, Bechara A, Fiore R, Nawabi H, Zhou H, Hoyo-Becerra C et al (2005) Dual functional activity of semaphorin 3B is required for positioning the anterior commissure. Neuron 48(1):63–75CrossRefPubMedGoogle Scholar
  8. 8.
    Ben-Zvi A, Ben-Gigi L, Klein H, Behar O (2007) Modulation of semaphorin3A activity by p75 neurotrophin receptor influences peripheral axon patterning. J Neurosci 27(47):13000–13011CrossRefPubMedGoogle Scholar
  9. 9.
    Suto F, Ito K, Uemura M, Shimizu M, Shinkawa Y, Sanbo M et al (2005) Plexin-a4 mediates axon-repulsive activities of both secreted and transmembrane semaphorins and plays roles in nerve fiber guidance. J Neurosci 25(14):3628–3637CrossRefPubMedGoogle Scholar
  10. 10.
    Yaron A, Huang PH, Cheng HJ, Tessier-Lavigne M (2005) Differential requirement for Plexin-A3 and -A4 in mediating responses of sensory and sympathetic neurons to distinct class 3 semaphorins. Neuron 45(4):513–523CrossRefPubMedGoogle Scholar
  11. 11.
    Germeyer A, Hamilton AE, Laughlin LS, Lasley BL, Brenner RM, Giudice LC et al (2005) Cellular expression and hormonal regulation of neuropilin-1 and -2 messenger ribonucleic acid in the human and rhesus macaque endometrium. J Clin Endocrinol Metab 90(3):1783–1790CrossRefPubMedGoogle Scholar
  12. 12.
    Swiercz JM, Worzfeld T, Offermanns S (2008) ErbB-2 and met reciprocally regulate cellular signaling via Plexin-B1. J Biol Chem 283(4):1893–1901CrossRefPubMedGoogle Scholar
  13. 13.
    Toyofuku T, Zhang H, Kumanogoh A, Takegahara N, Suto F, Kamei J et al (2004) Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev 18(4):435–447CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Braicu C, Chiorean R, Irimie A, Chira S, Tomuleasa C, Neagoe E et al (2016) Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy. Expert Rev Mol Med 7(18):e18CrossRefGoogle Scholar
  15. 15.
    Zhou Y, Gunput RA, Pasterkamp RJ (2008) Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci 33(4):161–170CrossRefPubMedGoogle Scholar
  16. 16.
    Chadborn NH, Ahmed AI, Holt MR, Prinjha R, Dunn GA, Jones GE et al (2006) PTEN couples Sema3A signalling to growth cone collapse. J Cell Sci 119(Pt 5):951–957CrossRefPubMedGoogle Scholar
  17. 17.
    Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R et al (2005) Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer 104(2):427–438CrossRefPubMedGoogle Scholar
  18. 18.
    Fan F, Wey JS, McCarty MF, Belcheva A, Liu W, Bauer TW et al (2005) Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene 24(16):2647–2653CrossRefPubMedGoogle Scholar
  19. 19.
    Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W et al (2006) Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res 66(1):46–51CrossRefPubMedGoogle Scholar
  20. 20.
    Kruger RP, Aurandt J, Guan KL (2005) Semaphorins command cells to move. Nat Rev Mol Cell Biol 6(10):789–800CrossRefPubMedGoogle Scholar
  21. 21.
    Xiang RH, Hensel CH, Garcia DK, Carlson HC, Kok K, Daly MC et al (1996) Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Genomics 32(1):39–48CrossRefPubMedGoogle Scholar
  22. 22.
    Roche J, Boldog F, Robinson M, Robinson L, Varella-Garcia M, Swanton M et al (1996) Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene 12(6):1289–1297PubMedGoogle Scholar
  23. 23.
    Tse C, Xiang RH, Bracht T, Naylor SL (2002) Human semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res 62(2):542–546PubMedGoogle Scholar
  24. 24.
    Xiang R, Davalos AR, Hensel CH, Zhou XJ, Tse C, Naylor SL (2002) Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Cancer Res 62(9):2637–2643PubMedGoogle Scholar
  25. 25.
    Shahi P, Wang CY, Chou J, Hagerling C, Veloso HG, Ruderisch A et al (2017) GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis. Oncogene 36(40):5567–5575CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Castro-Rivera E, Ran S, Thorpe P, Minna JD (2004) Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc Natl Acad Sci USA 101(31):11432–11437CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Regano D, Visintin A, Clapero F, Bussolino F, Valdembri D, Maione F et al (2017) Sema3F (semaphorin 3F) selectively drives an extraembryonic proangiogenic program. Arterioscler Thromb Vasc Biol 37(9):1710–1721.  https://doi.org/10.1161/ATVBAHA.117.308226 (Epub 2017 Jul 20) CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Bielenberg DR, Hida Y, Shimizu A, Kaipainen A, Kreuter M, Kim CC et al (2004) Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Investig 114(9):1260–1271CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Bielenberg DR, Klagsbrun M (2007) Targeting endothelial and tumor cells with semaphorins. Cancer Metastasis Rev 26(3–4):421–431CrossRefPubMedGoogle Scholar
  30. 30.
    Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ et al (2003) Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 63(17):5230–5233PubMedGoogle Scholar
  31. 31.
    Huang C, Wang Y, Huang JH, Liu W (2017) Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice. BMC Pharmacol Toxicol 18(1):55CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Herman JG, Meadows GG (2007) Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells. Int J Oncol 30(5):1231–1238PubMedGoogle Scholar
  33. 33.
    Muller MW, Giese NA, Swiercz JM, Ceyhan GO, Esposito I, Hinz U et al (2007) Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Int J Cancer 121(11):2421–2433CrossRefPubMedGoogle Scholar
  34. 34.
    Liang Y, Wang W, Huang J, Tan H, Liu T, Shang C et al (2015) Potential role of semaphorin 3A and its receptors in regulating aberrant sympathetic innervation in peritoneal and deep infiltrating endometriosis. PLoS ONE 10(12):e0146027CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Evanno E, Godet J, Piccirilli N, Guilhot J, Milin S, Gombert JM et al (2017) Tri-methylation of H3K79 is decreased in TGF-β1-induced epithelial-to mesenchymal transition in lung cancer. Clin Epigenetics 8(9):80CrossRefGoogle Scholar
  36. 36.
    Paullin T, Powell C, Menzie C, Hill R, Cheng F, Martyniuk CJ, Westerheide SD (2017) Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses. PLoS ONE 12(8):e0182930CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Wang Z, Ding M, Qian N, Song B, Yu J, Tang J, Wang J (2017) Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer. World J Surg Oncol 15(1):67CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ et al (2009) Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. Clin Cancer Res 15(22):6763–6770CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of PhysiologyFederal University of Rio Grande do SulPorto AlegreBrazil
  2. 2.Department of Physiology and PharmacologyFederal University of PelotasPelotasBrazil
  3. 3.Department of Gynecological Endocrinology and Reproductive MedicineHeidelberg UniversityHeidelbergGermany

Personalised recommendations